ARXT Adams Respiratory Therapeutics (MM)

NASHVILLE, Tenn., Nov. 14 /PRNewswire/ -- DaySpring Pharma today announced the addition John Thievon and Joe Williams to its Board of Directors. Each brings specific expertise to the fulfillment of DaySpring's business objectives. Mr. Kevin Esval, Chairman of DaySpring, stated, "John Thievon brings a robust professional background to the Board at a time when DaySpring's product portfolio is poised for significant growth in both prescription and OTC markets. His experience and tenure at Adams (NASDAQ:ARXT) offers DaySpring direct applications into immolating Adam's successful business plan." Mr. Thievon commented, "I am delighted to join DaySpring's Board. With its unique operating platform, current portfolio and pipeline, I hope to add to management's already considerable expertise." Mr. Thievon serves as Executive Vice President of Sales & Corporate Accounts. Previously, he has led Business Development, Commercial Operations and Marketing at Adams. Prior to Adams, Mr. Thievon held various positions with IMS Health Inc, and Ortho Pharmaceuticals. He holds a Bachelor of Business Administration degree from Pace University. Mr. Esval said of Mr. Williams, "Joe Williams' addition to the Board brings a wealth of experience in building organizations and capital raises in the health care marketplace. His background provides a tremendous advantage to DaySpring as it continues its aggressive growth plans. Mr. Williams commented, "I'm looking forward to participating on DaySpring's Board. The Company's passion for growth is similar to those that I co-founded or was an early investor". Mr. Williams was a co-founder, Chairman and CEO of Coventry Corporation, a large managed care organization as well as an early investor in other successful healthcare startup, including Nashville based Cumberland Pharmaceuticals. The recipient of a Bachelor of Science degree from Auburn University, he is also active with Angel Flight, a voluntary pilot organization and very involved in church and community activities. About DaySpring Pharma DaySpring Pharma is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription and non-prescription products for specialty markets in Women's Health, Pediatrics and Dermatology. For general information, please visit the company's website: http://www.dayspringpharma.com/ DATASOURCE: DaySpring Pharma CONTACT: Wade Smith of DaySpring Pharma, +1-770-639-3276, Web site: http://www.dayspringpharma.com/

Copyright